Wednesday, June 12, 2024 | Baltimore, MD

Rockville biotech OpGen shrinks headcount, scales down U.S. operations

November 16, 2023

OpGen Inc. (NASDAQ: OPGN) is the latest local biotech to overhaul its business — slashing its headcount, executive pay and functions — to conserve cash and try to stay afloat. The company, which develops rapid diagnostics for infectious diseases, announced this week it will lay off the majority of its staff and scale down its U.S. operations in Rockville.

Article Source: Washington Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.